
I was addicted to food but now I'm a Mounjaro addict – trolls say my ‘organs are f***ed' but I had no side effects
TikTok user Kharis kickstarted her fat jabs journey in January and had lost a staggering 2 stone by February.
3
3
3
After taking a break from Mounjaro - also regarded by some as the King Kong of weight loss jabs - Kharis decided to jump back on the medication in May.
During this month, the young mother managed to shed another stone, proudly sharing the epic results in a recent video.
To prove just how much weight and extra inches she had managed to burn off, Kharis uploaded a clip where she was wearing the same pyjama bottoms - but several months apart.
Following the three-month course of injecting herself in the tummy, Kharis now boasts a noticeably more toned stomach area, with a defined waist.
The mum - who said she used to be '' addicted to food '' - also claimed that she didn't suffer from any nasty side effects.
Some of the most common side effects on Mounjaro include nausea, diarrhea, vomiting, constipation and indigestion, experts have warned.
Kharis said: ''I've had non [none] at all luckily but my friend did get the nausea feeling but wasn't actually sick.''
Sharing the transformation on her page, the brunette beauty added that although she did join the gym, she's only popped inside for a workout twice.
''Need to start asap tho to try build some muscle,'' Kharis went on, claiming that before taking Mounjaro, she was ''classed as obese''.
As well as using the medication, which is licensed for patients with type 2 diabetes, Kharis also stuck to a calorie deficit to achieve the enviable results.
I LOVE my new 'Ozempic face' - it looks like I got jawline filler, I look 10 years younger AND I lost 60lbs
''POV: you were just a girl addicted to food but now you're just a girl addicted to Mounjaro,'' she said in the video.
Viewers left divided
The TikTok clip, which was posted under the username @ khar1sx, has clearly left many open-mouthed, as it has quickly racked up a whopping 285k views in just two days.
Social media users were gobsmacked by Kharis' incredible weight loss and more than 140 viewers rushed to share their thoughts.
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
One person said: ''That's amazing of just 3 month kharis.''
''You look amazing! Well done,'' another chimed in.
''Wow, you smashed it girl. So happy for you,'' someone else added.
But while many were praising the mum-of-two, not everyone was so supportive, as one critic warned: ''Have fun when your vital organs are f****d.''
Hitting back at the harsh comment - which has been liked by more than a dozen others - the mother said: ''I believe if used correctly Mounjaro is safe but each to their own.''
Be aware of the dangers
Although many were impressed with Kharis' weight loss, those debating whether to start using Mounjaro should know that it can have fatal consequences.
And experts and NHS medics have shared a stern warning about the dangers of taking such medications without a prescription.
What are the other side effects of weight loss jabs?
Like any medication, weight loss jabs can have side effects.
Common side effects of injections such as Ozempic include:
Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts.
Vomiting: Can occur, often in conjunction with nausea.
Diarrhea: Some people experience gastrointestinal upset.
Constipation: Some individuals may also experience constipation.
Stomach pain or discomfort: Some people may experience abdominal pain or discomfort.
Reduced appetite: This is often a desired effect for people using Ozempic for weight loss.
Indigestion: Can cause a feeling of bloating or discomfort after eating.
Serious side effects can also include:
Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting.
Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon.
Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic.
Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic.
Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.
Sun GP Dr Zoe Williams acknowledged that Mounjaro, which could soon be rolled out on the NHS, can save the lives of people with 'life-threatening levels of obesity.'
But despite this, the NHS advised people to 'never take an anti-obesity medicine if it has not been prescribed to you.'
The NHS warned: "These types of medicines may not be safe for you and can cause serious side effects.'
Mounjaro works by suppressing your appetite, making you feel fuller for longer.
The injections, which are administered every seven days, are licensed for patients with type 2 diabetes.
They are also available to assist those who are clinically obese (with a Body Mass Index of 30 or over).
The drugs, which have been widely regarded as 'fat jabs', can be prescribed by a practitioner - such as a doctor, nurse or a pharmacist-independent prescriber.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
24 minutes ago
- The Independent
What to know about bovine tuberculosis as disease hits Diddly Squat Farm
Jeremy Clarkson 's Diddly Squat Farm in the Cotswolds has been hit by an outbreak of bovine tuberculosis (bTB) among its cattle. Clarkson announced on 31 July that the farm team was "devastated" after a pregnant cow contracted the disease, with tests for the beloved bull Endgame proving inconclusive. Following failed biannual tests for some cattle, the farm is now under restrictions, preventing the buying or selling of cows, though the Diddly Squat shop remains unaffected. The infected pregnant cow, carrying twins, will be culled, a decision Clarkson described as "awful" and emotionally distressing for the farm. Bovine TB is a chronic respiratory disease that primarily affects cattle, often leading to culling to control its spread, though human transmission is very rare. What is bovine tuberculosis? Everything you need to know about the disease affecting Jeremy Clarkson's Diddly Squat farm


The Independent
24 minutes ago
- The Independent
Alzheimer's ‘wonder drug' slows progression of disease by four years - and could even reverse it
An Alzheimer's 'wonder drug' can delay the progression of the disease by four years, according to a new study. Researchers found that patients who were given the drug lecanemab in the earliest days of their disease reported an improvement, or no decline at all, in cognitive function. The trial of 478 patients who stayed on the drug for four years saw their dementia score rise by an average of 1.75 over the whole period - a score significantly lower than the average rise of one or two points over one year. Almost one million people in the UK suffer from dementia, with Alzheimer's the most common form of the disease. Urgent demand for new treatments is increasing as the number is expected to rise to 1.4 million by 2040. The new data presented at the Alzheimer's Association International Conference in Toronto suggested the drug was most promising for those with low levels of tau, the protein that grows as Alzheimer's progresses. In a subgroup of patients with low levels of tau, promising results showed 69 per cent of the group had no decline at all over four years, and 56 per cent saw an improvement in their cognitive scores. Speaking to The Telegraph, Professor Christopher Van Dyck, the director of the Alzheimer's Research unit at the Yale school of medicine and the study leader, said: 'The thing I really focus on is the time saved. You will get worse over time, but it will take longer to get there.' Lecanemab was approved for use in the UK last year after trials showed its effectiveness in slowing the progression of the disease. It is a disease-modifying drug, which means that it was developed to tackle the causes of Alzheimer's disease rather than only relieving the symptoms. It works by targeting the protein amyloid, which is thought to build up in the brain and become toxic to brain cells, causing Alzheimer's symptoms. Other similar drugs, like donanemab, have also been shown to slow the rate at which memory and thinking get worse by more than 20 per cent. Both drugs are approved by the Medicines and Healthcare products Regulatory Agency (MHRA) but were rejected for use by the NHS because the benefits were deemed to be 'too small' to justify the cost. Dr Sheona Scales, the director of research at Alzheimer's Research UK, told The Telegraph: 'These latest findings offer renewed hope that Alzheimer's treatments can meaningfully change the course of the disease, not just slow decline in the short term. 'New long-term data show that the benefits of donanemab may continue even after treatment ends, and people on lecanemab for up to four years maintained cognitive gains, with some even improving. Among those treated early with lecanemab and with low levels of tau, over half showed no decline after four years. 'This is the first wave of disease-modifying treatments for Alzheimer's and, while the progress is encouraging, there are still many pieces of the puzzle we don't yet have.'


BBC News
24 minutes ago
- BBC News
Jersey fundraiser finishes challenge in memory of her mum
A Jersey fundraiser finished her challenge to run 5k (3.2miles) every day through the month of July in memory of her Daly's mum, Nicola, died from malignant melanoma five years ago, which is a type of skin cancer that can spread to other areas of the 27-year-old has raised more than £6,400 for MacMillan Jersey, which supported her mum during her cancer Daly was joined by friends and family throughout her runs and they gathered at the Waterfront Gardens to cheer her on as she finished the challenge. Ms Daly has been sharing her challenge on social media to also make more people aware of the dangers of skin said: "People think it's just skin cancer and you can cut it out and it's gone but that wasn't the case with my mum and it's not the case for a lot of people."Ms Daly added: "The most emotional thing was I just wish she was here," adding: "She would've been there every step of the way and I know she is there but I can't see her or talk to her".It was an emotional finish to the fundraising as Ms Daly shed some tears as she crossed the finish line, and also said: "I've never done anything like this before". Megan Winton was one of the runners who joined Ms Daly on her final run on said it was "for a great cause" and "whatever we could do to help, we jumped up to it"."It was emotional and I'm glad I had my sunglasses as we all got a little bit choked up because it was so beautiful and it's what it's all been about," Ms Winton. Andrew Gardham from MacMillan Jersey liaised with Ms Daly on her fundraising challenge for the cancer said: it was "absolutely fantastic to see Daisy finish off after all of her hard work", and that it was "really important for us to have fundraisers like Daisy".Mr Gardham added: "Not only has Daisy raised fantastic funds but also by sharing her story so bravely, it's been so impactful for other people to be diligent and to be careful in the sun." MacMillan Jersey advises that people stay in shade when the sun is at its strongest, cover up skin when UV rays are high and wear suncream on exposed skin to reduce the risks of getting skin cancer.